Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Wheatley

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
ACS Synthetic Biology|October 4, 2022
SpyPhage: A Cell-Free TXTL Platform for Rapid Engineering of Targeted Phage TherapiesSahan B W Liyanagedera, Joshua Williams, Joseph P Wheatley, et al.
Molecular Cancer|July 6, 2010
p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarkerMagdalena B Flak, Claire M Connell, Claude Chelala, et al.
Scientific Reports|March 14, 2019
Engulfment, persistence and fate of Bdellovibrio bacteriovorus predators inside human phagocytic cells informs their future therapeutic potentialDhaarini Raghunathan, Paul M Radford, Christopher Gell, et al.
Plos Pathogens|March 8, 2013
The Plasmodium berghei Ca(2+)/H(+) exchanger, PbCAX, is essential for tolerance to environmental Ca(2+) during sexual developmentDavid S Guttery, Jon K Pittman, Karine Frénal, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 8, 2016
Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3M M Vickers, C Lee, D Tu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trialsP Wheatley-Price, F Blackhall, S-M Lee, et al.
Current Oncology (Toronto, Ont.)|March 7, 2018
Regional process redesign of lung cancer care: a learning health system pilot projectM Fung-Kee-Fung, D E Maziak, J R Pantarotto, et al.
Plos Pathogens|November 14, 2015
Plasmodium P-Type Cyclin CYC3 Modulates Endomitotic Growth during Oocyst Development in MosquitoesMagali Roques, Richard J Wall, Alexander P Douglass, et al.
Investigational New Drugs|February 6, 2020
A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurrently or sequentially in patients with advanced, incurable solid malignanciesJ Nehra, P A Bradbury, P M Ellis, et al.
Autophagy|February 26, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>Daniel J Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
ACS Synthetic Biology|October 4, 2022
SpyPhage: A Cell-Free TXTL Platform for Rapid Engineering of Targeted Phage TherapiesSahan B W Liyanagedera, Joshua Williams, Joseph P Wheatley, et al.
Molecular Cancer|July 6, 2010
p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarkerMagdalena B Flak, Claire M Connell, Claude Chelala, et al.
Scientific Reports|March 14, 2019
Engulfment, persistence and fate of Bdellovibrio bacteriovorus predators inside human phagocytic cells informs their future therapeutic potentialDhaarini Raghunathan, Paul M Radford, Christopher Gell, et al.
Plos Pathogens|March 8, 2013
The Plasmodium berghei Ca(2+)/H(+) exchanger, PbCAX, is essential for tolerance to environmental Ca(2+) during sexual developmentDavid S Guttery, Jon K Pittman, Karine Frénal, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 8, 2016
Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3M M Vickers, C Lee, D Tu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trialsP Wheatley-Price, F Blackhall, S-M Lee, et al.
Current Oncology (Toronto, Ont.)|March 7, 2018
Regional process redesign of lung cancer care: a learning health system pilot projectM Fung-Kee-Fung, D E Maziak, J R Pantarotto, et al.
Plos Pathogens|November 14, 2015
Plasmodium P-Type Cyclin CYC3 Modulates Endomitotic Growth during Oocyst Development in MosquitoesMagali Roques, Richard J Wall, Alexander P Douglass, et al.
Investigational New Drugs|February 6, 2020
A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurrently or sequentially in patients with advanced, incurable solid malignanciesJ Nehra, P A Bradbury, P M Ellis, et al.
Autophagy|February 26, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>Daniel J Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, et al.
Pageof 10